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INTRODUCTION
Intracranial meningioma makes up 15–20% of primary 
brain tumors and is the most common primary adult brain tu-
mor [1]. The predominant treatment of intracranial menin-
gioma is surgical resection [2,3].
However, tumor recurrence or progression can be a signif-
icant problem after surgery because of the involvement of ad-
jacent cranial nerves or major intracranial arteries. Treatment 
of small-size tumors with surgical removal can have compli-
cations and may be contentious. In such cases, gamma knife 
surgery is a feasible alternative treatment modality [4,5]. Thus, 
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Background    The predominant treatment modality for meningioma is surgical resection. However, 
gamma knife radiosurgery is also an important treatment modality for meningioma that is small or can-
not be completely removed because of its location. In this study, we evaluated the effectiveness and 
long-term results of radiosurgical treatment for meningioma in our institution.
Methods    We studied 628 patients (130 men and 498 women) who underwent gamma knife 
radiosurgery for intracranial meningioma, which is radiologically diagnosed, from Jan 2008 to Nov 
2012. We included patients with single lesion meningioma, and followed up after 6 months with imag-
ing, and then at 24 months with a clinical examination. Patients with high-grade meningioma or multi-
ple meningiomas were excluded. We analyzed each of the factors associated with progression free 
survival. The median patient’s age was 56.8 years. Maximal dosage was 27.8 Gy and marginal dosage 
was 13.9 Gy. 
Results    The overall tumor control rate was 95%. Twenty-eight patients (4.4%) showed evi-
dence of tumor recurrence. Ninety-eight patients (15%) developed peritumoral edema (PTE) after 
gamma-knife surgery; two of them (2%) underwent surgical resections due to PTE. Nine patients had 
craniotomy and tumor removal after gamma knife surgery.
Conclusion    Gamma knife surgery for intracranial meningioma has proven to be a safe and effec-
tive treatment tool with successful long-term outcomes. Gamma knife radiosurgery can be especially 
effective in cases of remnant meningioma after surgical resection or where PTE is not present.
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it has become an important management tool for patients 
with intracranial meningioma. 
At 5 years after gamma knife surgery, tumor control rates 
of 90–100% are reported for intracranial meningioma [6-9]. 
However, reports on long-term outcomes for meningioma 
are limited because of its pathologic characteristics; it is most 
often benign and so patients do not follow-up at out-patient 
departments.
We reviewed clinical outcomes in 628 consecutive patients 
with meningioma.
MATERIALS AND METHODS
Patients
We studied 628 patients who underwent gamma knife ra-
diosurgery for intracranial incidental meningioma from Jan 
2008 to Nov 2012 at the Yonsei University College of Medicine. 
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We included patients with single lesion meningioma and 
followed up after 6 months with imaging, and then at 24 
months with a clinical examination. The median patient age 
at the time of gamma knife treatment was 56.8 years (28–83 
years). Of the 628 patients, 130 (20%) were male, and 498 (80%) 
were female. In cases in which surgery was not performed 
and histological diagnosis was not obtained, the diagnosis 
was confirmed by computed tomography (CT) or magnetic 
resonance imaging (MRI). Clinical follow-up was conducted 
between 1 to 79 months after gamma knife surgery (median 
37 months). Prior resections were performed in 131 patients 
(20.8%). Institutional Review Board (IRB) approval was ob-
tained from the severance hospital Yonsei University health 
system (IRB approval number 4-2015-0604).
Gamma knife technique 
Tumor locations are listed in Table 1. T1-weighted images 
with gadobutrol (Gd, Gadovist; Bayer Schering Pharma AG, 
Leverkusen, Germany) enhancement and T2-weighted im-
ages (repetition time 25, field of view 250 mm, matrix: 256× 
256 mm). Gamma knife surgery was performed using Leksell 
Gamma Knife type C or Perfexion (Elekta Instrument AB, 
Stockholm, Sweden).
Patients underwent gamma knife surgery after application 
of local anesthesia for stereotactic head frame. After frame 
application, MRI was conducted in the axial plane. Confor-
mal and selective dose plans were created, always using multi-
ple isocenters. Dose selection was based on individual factors 
that included age, prior exposure to radiation therapy, tumor 
volume, tumor location, and neurological status by using the 
GammaPlan treatment planning software. The median mar-
ginal and maximal dose delivered to the tumor was 13.9 Gy 
(range, 9 to 19 Gy) and 27.8 Gy (range, 20 to 36 Gy), respec-
tively.
Serial imaging follow-ups were performed using MRI to ex-
amine changes in tumor volume, peritumoral edema (PTE), 
and hydrocephalus; CT was performed when the MRI results 
were in contraindication.
Data was analyzed using the chi-square, Fisher exact, and 
Kruskal-Wallis tests. Multivariate analysis was carried out us-
ing the Cox proportional hazards regression analysis.
 The Statistical Package for the Social Sciences version 
20.0.0 (IBM, Armonk, NY, USA) was used for all statistical 
analyses.
Long-term tumor control and radiation-related complica-
tion rates were determined using the Kaplan-Meier method. 
Univariate testing was performed using log rank test.
RESULTS
Clinical follow-up data was available in 628 patients (130 
men and 498 women). Histopathological diagnoses was not 
confirmed in 300 cases and Grade I meningioma was detected 
in 128 cases. The overall tumor control rate was 95%. Twen-
ty-eight patients (4%) showed evidence of tumor recurrence. 
Ninety-eight patients (15%) developed PTE after gamma-
knife surgery. Of these, 76 patients were treated with medi-
cines, and 31 of them fully recovered after this treatment. Two 
patients (2%) had surgical resection for PTE.
Overall, the median progression free survival (PFS) time 
was 75 months, and the overall 5-year PFS (5YR PFS) was 
94.7% (Fig. 1).
The median PFS for patients older and younger than 65 
years was 69 and 70.9 months, respectively. The 5YR PFS for 
patients older and younger than 65 years was 69.0% and 
70.9%, respectively (p-value=0.986) (Table 2).
In men, the median PFS was 69.1 months, while it was 
76.1 months for women (p-value=0.065). The median PFS for 
patients with and without PTE was 85.3 and 96.5 months, re-
spectively. The 5YR PFS of patients with and without PTE was 
69.0% and 76.0%, respectively (p-value=0.000) (Table 2).
Gamma Knife radiosurgery was the primary treatment for 
497 patients (79.2%), while 131 patients (20.8%) had previous-
Table 1. Demographics for the 628 patients who underwent gam-
ma knife surgery
Factor Total: 628
Gender Male 130
Female 498
Age Mean (yr) 56.8±11.3
Location Supratentorial 179
Middle cranial fossa 143
Cerebellopontine angle 100
Parasagittal 97
Falx 72
Infratentorial convexity 31
Intraventricular 6
0.0                     20.0                    40.0                    60.0                     80.0
FUD
1.0
0.8
0.6
0.4
0.2
0.0
Fig. 1. Overall survival. FUD, follow-up duration (months).
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ly undergone open surgery. The mean period to gamma knife 
surgery after open surgery was 40 months (range, 0 to 227 
months). Nine patients underwent craniotomy and tumor 
removal after gamma knife surgery (Table 2).
The medial PFS was 77.4 months for patients for whom the 
primary treatment was gamma knife surgery and 62.3 months 
for those who had previously undergone open surgery. The 
corresponding values for 5YR PFS were 97.9% and 81.8%. 
The only factors showing tendency for survival in the multi-
variate analysis was PTE (Table 3).
DISCUSSION 
Over the last two decades, gamma knife surgery has be-
come an alternative component in multimodal management 
of primary and surgically removed intracranial meningioma. 
It has been applied frequently in patients in whom the menin-
gioma is located in challenging location, for solitary, small 
tumors or for patients showing recurrence after incomplete 
resections [10]. It has been demonstrated to be effective for 
controlling tumor growth.
Most previous studies reporting gamma knife surgery for 
intracranial meningioma had follow-up periods of fewer than 
5 years [7,11-13]. Only few studies have provided long-term 
follow-up analysis.
In these few studies, the overall tumor control rates were 
–86–100% with minimal complications to vital structures 
[14,15].
Kondziolka et al. [16] reported patient outcomes at up to 10 
years after radiosurgery and found a tumor control rate of 95%. 
In a study in which adjacent or new tumor growth away from 
the primary target was considered as treatment failure, the tu-
mor control rate dropped to 89% at 10 years [17]. In the Mayo 
clinic study of larger (>10 mL) benign meningiomas, Bledsoe 
et al. [18] reported a tumor control rate of 99% at 7 years and 
a neurological complication rate of 44% in supratentorial tu-
mors and 18% in skull-base tumors. Further, Han et al. [19] 
reported outcomes after gamma knife surgery for 63 skull-
based meningiomas treated with a mean marginal isodose of 
12.7 Gy. The overall tumor control rate was 90%, with follow-
up period ranging from 12 to 60 months.
In our study, the overall tumor control rate was 95%. Twen-
ty-eight patients (4%) showed evidence of tumor recurrence.
Couldwell et al. [20] analyzed patterns for failure after gam-
ma knife surgery for benign meningiomas and reported a 
higher likelihood of failure in cavernous sinus meningiomas. 
In a recent study, tumor progression after gamma knife surgery 
was high in patients treated with incomplete coverage, with 
cavernous sinus or with meningiomatosis, despite benign tu-
mor histology.
Relatively fewer recurrences have been reported for patients 
with meningiomas who received higher marginal doses (>14 
Gy) in comparison with those who received lower doses (10–
Table 2. Five-year progression free survival (5YR PFS) and me-
dial progression free survival (mPFS) of patients with asymptom-
atic intracranial meningioma
5YR PFS (%) mPFS (mo) p-value
Age  0.986 
65> 96.5 69.0
65≤ 94.4  70.9
Gender   0.065
Male  69.1
Female   76.1
PTE   <0.001
Yes 85.3 69.0
No 96.5  76.0
Surgery   0.017
Previous done 81.8 62.3
No 97.9  77.4
PTE, peritumoral edema
Table 3. Multivariate analysis
p-value 95% CI
Age over 65 0.238 0.711 1.089
Gender 0.086 0.661 1.028
Max dose (Gy) 0.499 0.701 1.189
Marginal dose (Gy) 0.112 0.909 2.500
PTE 0.079 0.619 1.027
Location 0.676 0.785 1.308
CI, confidence interval; PTE, peritumoral edema
0.0                     20.0                    40.0                    60.0                     80.0
FUD
Fig. 2. Influence of primary surgery or post-surgery remnant le-
sion radiation on progression free survival. FUD, follow-up dura-
tion (months).
1.0
0.8
0.6
0.4
0.2
0.0
Primary
Remnant
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12 Gy) [14].
Various factors may influence the long-term outcomes and 
likelihood of complications. Kondziolka et al. [16] reported 
prior radiation therapy (p<0.0001) and high-grade tumors 
(p<0.0001) as factors associated with a worse PFS. Age, sex, 
tumor volume, and margin dose were not associated with PFS. 
DiBiase et al. [11] reported that male patients and patients 
with tumor size greater than 10 cc were more likely to have a 
worse prognosis. The reason for female patients having a 
higher tumor control rate is unknown, but one hypothesis is 
related to the presence of hormone receptors in meningiomas. 
Sexual hormone assays of meningiomas exhibit the presence 
of estrogen, progesterone, and androgen receptors [21]. Fur-
ther, patients treated with less conformal plans to cover the 
dural tail have been reported to have better outcomes. Previ-
ous studies demonstrate the need to adequately cover the du-
ral tail in patients treated with gamma knife surgery for be-
nign intracranial meningiomas. Additionally, previous surgery 
to treat a lesion larger than 10 cc was found to be a significant 
factor affecting the likelihood of tumor control [11]. Radia-
tion-related complications were associated with tumor loca-
tion (convexity/falx) and large tumor volume [22]. 
In our study, previous surgery (Fig. 2) and presence of PTE 
(Fig. 3) were identified as factors influencing PFS. So we rec-
ommend that primary surgery was needed before perform-
0.0                     20.0                    40.0                    60.0                     80.0
FUD
Fig. 4. Influence of gender on progression free survival. FUD, fol-
low-up duration (months).
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Fig. 3. Influence of peritumoral edema on progression free sur-
vival. FUD, follow-up duration (months).
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Fig. 5. Magnetic resonance images of a representative case. A 
62-year-old man received gamma knife surgery for parasagittal 
meningioma with invasion of superior sagittal sinus. A: Axial T1-
weighted magnetic resonance (MR) image obtained in Dec 2006 
showing homogeneous enhancing round mass with invasion of 
superior sagittal sinus. B: Axial T1-weighted MR image from Aug 
2009 (post gamma knife surgery 32 months) showing increased 
heterogeneous enhancing round mass with aggravated peritu-
moral edema. C: Axial T1-weighted MR image from Sep 2009 
(post-operation) showing no remnant lesion.
A
B
C
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ing gamma knife surgery if there is PTE. Male patients tend-
ed to have poorer PFS than female patients (Fig. 4), although 
this finding did not reach statistical significance. Further, older 
patients (≥65) showed similar long-term tumor control rates 
compared to younger patients (<65). This provides evidence 
that gamma knife surgery for meningioma is plausible even 
for elderly patients. The only factor that showed tendency on 
multivariate analysis was PTE. In this report, patients with-
out PTE had a significantly higher 5YR PFS than those with 
PTE (96.5% vs. 85.3%, p-value<0.001), and this remained 
tendency on multivariate analysis (Table 3).
Our study does have some limitations. It was retrospective 
and involved cases that were not confirmed by histopathology. 
Specifically, for 500 cases, histological confirmation was not 
obtained. Of the 128 cases that were histopathologically con-
firmed, 100 were of World Health Organization (WHO) grade 
I, 25 were of WHO grade II, and 3 were of WHO grade III.
A small percentage of meningiomas appear to have malig-
nant potential [23,24]. According to the literature on menin-
gioma, diverse behaviors of the tumors are described. One of 
our patients, a 62-year-old man, received gamma knife sur-
gery for a parasagittal meningioma with invasion of the su-
perior sagittal sinus (Fig. 5A). After 32 months, follow-up 
with MRI revealed increasing tumor size with PTE (Fig. 5B). 
We performed total resection of that lesion, which had atypi-
cal pathology for meningioma (WHO grade III) (Fig. 5C).
According to our results, gamma knife surgery for intracra-
nial meningioma is safe and effective with successful long-
term outcomes. It can be a highly effective treatment modali-
ty particularly in cases of remnant meningioma after surgical 
resection as well as in cases without PTE. 
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